Thompson Davis & CO. Inc. lessened its position in shares of Nutex Health Inc. (NASDAQ:NUTX – Free Report) by 4.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,850 shares of the company’s stock after selling 925 shares during the period. Thompson Davis & CO. Inc. owned about 0.40% of Nutex Health worth $692,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Truist Financial Corp grew its holdings in Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company’s stock worth $1,127,000 after acquiring an additional 6,454 shares in the last quarter. Legato Capital Management LLC boosted its holdings in shares of Nutex Health by 26.8% in the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company’s stock valued at $1,004,000 after buying an additional 6,697 shares in the last quarter. Baader Bank Aktiengesellschaft acquired a new position in shares of Nutex Health in the 4th quarter valued at $206,000. Drive Wealth Management LLC acquired a new position in shares of Nutex Health in the 4th quarter valued at $1,122,000. Finally, Beaird Harris Wealth Management LLC acquired a new position in shares of Nutex Health in the 3rd quarter valued at $69,000. Institutional investors and hedge funds own 5.32% of the company’s stock.
Analyst Ratings Changes
Several research analysts have recently issued reports on the stock. Maxim Group upped their target price on shares of Nutex Health from $50.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Benchmark upped their target price on shares of Nutex Health from $45.00 to $60.00 and gave the company a “buy” rating in a report on Tuesday, November 12th.
Nutex Health Stock Down 6.6 %
NUTX stock opened at $57.60 on Friday. The company has a fifty day moving average price of $42.42 and a 200 day moving average price of $30.68. Nutex Health Inc. has a 12 month low of $4.16 and a 12 month high of $69.45. The company has a market cap of $313.34 million, a price-to-earnings ratio of -6.14 and a beta of 0.20. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74.
Nutex Health Company Profile
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
- Five stocks we like better than Nutex Health
- How to Read Stock Charts for Beginners
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Short Selling: How to Short a Stock
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What Are Dividends? Buy the Best Dividend Stocks
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTX – Free Report).
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.